My assumption is that the Chiesi partnership will discourage any future buyout by another pharma company as they still wouldn't get the rights already given to Chiesi unless they worked out some extra deal with them. I guess it all remains to be seen though as I can only speculate.
News 
Market Data 
Discover 
